A5011696916- Bipolar Disorder and Treatment
- Maternal Mental Health During Pregnancy and Postpartum
- Schizophrenia research and treatment
- Child and Adolescent Psychosocial and Emotional Development
- Treatment of Major Depression
- Electroconvulsive Therapy Studies
- Tryptophan and brain disorders
- Neuroendocrine regulation and behavior
- Personality Disorders and Psychopathology
- Obsessive-Compulsive Spectrum Disorders
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Attention Deficit Hyperactivity Disorder
- Genetic Syndromes and Imprinting
- Attachment and Relationship Dynamics
- Autism Spectrum Disorder Research
- Adolescent and Pediatric Healthcare
- Circadian rhythm and melatonin
- Infant Development and Preterm Care
- Pregnancy and Medication Impact
- Neurological Disorders and Treatments
- Mental Health Treatment and Access
- Fetal and Pediatric Neurological Disorders
- Neuroscience, Education and Cognitive Function
- Mental Health and Psychiatry
- Stress Responses and Cortisol
Aziende Socio Sanitaria Territoriale Rhodense
2019-2022
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2011-2021
University of Milan
2010-2021
Creative Research Enterprises (United States)
2017
Ospedale Maggiore
2008-2017
AstraZeneca (France)
2017
Bristol-Myers Squibb (Germany)
2017
Icahn School of Medicine at Mount Sinai
2010
This study aimed to determine the extent of impairment in social and non-social cognitive domains an ecological context comparing bipolar (BD), schizophrenic (SKZ) patients healthy controls (HC). The sample was enrolled at Department Psychiatry Policlinico Hospital, University Milan; it includes stabilized SKZ (n = 30), euthymic 18) HC 18). Patients completed psychiatric assessment rating scales, Brief Assessment Cognition Schizophrenia (BACS) Executive Social Battery (ESCB) that contains...
Recent literature considers duration of illness (DI) and untreated (DUI) as important factors influencing outcome in many psychiatric conditions. The aim the present article is to analyze relationship between DI DUI, pharmacological response different disorders with particular emphasis on neurodegenerative aspects. An updated review current was conducted through PubMed order compare studies focused treatment major psychoses depressive/anxiety disorders. A significant body evidence shows that...
Generalized anxiety disorder (GAD) is a chronic and disabling condition. The aim of this study was to evaluate the effectiveness low-dose augmentative quetiapine (mean dose=50 mg/day) in patients with GAD partial/no response selective serotonin reuptake inhibitors (SSRIs). Twenty SSRIs were randomized (n=10) or placebo for 8 weeks, continuing their treatment SSRIs. Analyses variance repeated measures on Hamilton Anxiety Rating Scale (HAM-A) Clinical Global Impression (CGIs; severity illness)...
Background: Both obesity and depression are medical conditions associated with severe disability biological abnormalities. Our aim was to study associations between Body Mass Index (BMI), changes in women affected by overweight or obesity. Methods: Depressive symptoms were evaluated the Beck Depression Inventory II (BDI-II) questionnaire 200 overweight/obesity (mean age of sample 52.7 ± 12.9 years, BMI 33.8 5.5 kg/m2). A blood obtained for evaluation biochemical (oxytocin vitamin D),...
Objective The purpose of the study was to compare antipsychotic monotherapies in terms time discontinuation a sample schizophrenia patients followed-up for 36 months. Methods Two hundred and twenty patients, treated with monotherapy psychiatric outpatient clinics Universities Milan Utrecht were included study. A survival analysis (Kaplan–Meier) 36-month follow-up period performed single treatment groups. End-point considered as recurrence, side effects or non-compliance. Results Patients...